Editas Medicine (EDIT)
(Delayed Data from NSDQ)
$3.21 USD
-0.17 (-5.03%)
Updated Oct 7, 2024 04:00 PM ET
After-Market: $3.22 +0.01 (0.31%) 6:36 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Cash flow Statements
Fiscal Year End for Editas Medicine, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -153.22 | -220.43 | -192.50 | -115.98 | -133.75 |
Depreciation/Amortization & Depletion | 1.24 | 6.34 | 5.05 | 3.96 | 2.83 |
Net Change from Assets/Liabilities | -1.59 | 8.18 | -21.41 | -102.22 | 65.93 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 21.39 | 28.57 | 45.06 | 34.39 | 24.32 |
Net Cash From Operating Activities | -132.18 | -177.35 | -163.80 | -179.84 | -40.67 |
Property & Equipment | -4.72 | -4.10 | -7.98 | -7.15 | -6.07 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.99 | 118.17 | -46.49 | -133.37 | 18.32 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -3.73 | 114.07 | -54.47 | -140.52 | 12.25 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 118.04 | 1.28 | 282.11 | 224.12 | 131.82 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 118.04 | 1.28 | 282.11 | 224.12 | 131.82 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -17.87 | -62.00 | 63.84 | -96.24 | 103.41 |
Cash at Beginning of Period | 145.40 | 207.40 | 143.56 | 239.80 | 136.40 |
Cash at End of Period | 127.53 | 145.40 | 207.40 | 143.56 | 239.80 |
Diluted Net EPS | -2.02 | -3.21 | -2.85 | -1.98 | -2.68 |
Fiscal Year End for Editas Medicine, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -129.56 | -61.95 | -153.22 | -134.35 |
Depreciation/Amortization & Depletion | NA | -0.77 | -0.31 | 1.24 | 1.88 |
Net Change from Assets/Liabilities | NA | 11.21 | 4.80 | -1.59 | 6.49 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 12.18 | 7.59 | 21.39 | 16.04 |
Net Cash From Operating Activities | NA | -106.93 | -49.87 | -132.18 | -109.94 |
Property & Equipment | NA | -5.37 | -1.87 | -4.72 | -3.41 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 52.57 | -2.87 | 0.99 | -63.16 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 47.21 | -4.75 | -3.73 | -66.57 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.51 | 0.19 | 118.04 | 117.53 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 0.51 | 0.19 | 118.04 | 117.53 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -59.21 | -54.43 | -17.87 | -58.98 |
Cash at Beginning of Period | NA | 127.53 | 127.53 | 145.40 | 145.40 |
Cash at End of Period | NA | 68.32 | 73.10 | 127.53 | 86.42 |
Diluted Net EPS | NA | -0.82 | -0.76 | -0.20 | -0.55 |